Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.79 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.70 |
| ▸ | CYP2E1 | P05181 | 3/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.70 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.70 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.70 |
| ▸ | CYP4B1 | P13584 | 3/20 | 0.70 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.70 |
| ▸ | CYP3A5 | P20815 | 3/20 | 0.70 |
| ▸ | CYP2A7 | P20853 | 3/20 | 0.70 |
| ▸ | CYP3A7 | P24462 | 3/20 | 0.70 |
| ▸ | CYP2F1 | P24903 | 3/20 | 0.70 |
| ▸ | CYP2C18 | P33260 | 3/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.70 |
| ▸ | CYP2J2 | P51589 | 3/20 | 0.70 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,3,5-Trimethoxybenzene SCHEMBL28493 | 0.89 | ALDH1A1 (1.00) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| SCHEMBL2274524 | 0.86 | ABL1 (0.79) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| 1,3,5-Trimethoxybenzene SCHEMBL28740008 | 0.85 | ALDH1A1 (0.92) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| 1,3,5-Trimethoxybenzene SCHEMBL28416912 | 0.85 | ALDH1A1 (0.92) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| 1,3,5-Trimethoxybenzene SCHEMBL28557531 | 0.85 | ALDH1A1 (0.92) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| SCHEMBL23743214 | 0.84 | CYP1A1 (1.00) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| Water SCHEMBL27689515 | 0.84 | ABL1 (0.76) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| SCHEMBL2407878 | 0.84 | CYP1A1 (0.74) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| Ethane SCHEMBL27670651 | 0.84 | ABL1 (0.76) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| SCHEMBL2952197 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106699520-A | Method for synthesizing 3,3',5,5'-tetramethoxyl-4,4'-biphenol | 甘肃省化工研究院 | 2017-05-24 | — | — | CN | claimed |
| WO-2024126567-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| EP-4306614-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023198671-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023198673-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023198669-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-19 | — | — | WO | disclosed |
| EP-4261269-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2023-10-18 | — | — | EP | disclosed |
| US-20230323207-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-20230323207-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| EP-4008759-A1 | POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM | Merck Patent GmbH (DE) | 2022-06-08 | — | — | EP | disclosed |
| US-7351339-B2 | Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-01 | — | — | US | disclosed |
| EP-1470136-B1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AG (DE) | 2007-03-28 | — | — | EP | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| EP-1472201-A2 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-03 | — | — | EP | disclosed |
| EP-1470136-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003062171-A2 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | WO | disclosed |
| WO-2003062251-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | WO | disclosed |
| EP-0731786-B1 | BIPHENYL IODINATED DERIVATIVES AND THEIR DIAGNOSTIC USE | BRACCO SPA (IT) | 1998-10-21 | — | — | EP | disclosed |
| EP-0731786-A1 | BIPHENYL IODINATED DERIVATIVES AND THEIR DIAGNOSTIC USE | BRACCO S.p.A. (IT) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995015307-A1 | BIPHENYL IODINATED DERIVATIVES AND THEIR DIAGNOSTIC USE | BRACCO S.P.A. (IT) | 1995-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | ALDH1A1 4228/4885CYP1A1 4876/4885CYP1B1 4836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.